Kisspeptin & Upstream Control of the HPG Axis
KNDy Neurons, Neurokinin B, Dynorphin, and the GnRH Pulse Generator
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Investigational (research peptide; not approved for low testosterone)
Reference only. Not medical advice.
What can go wrong
Kisspeptin is investigational. Research-grade or gray-market peptides marketed for libido or testosterone are not quality-controlled, not proven effective, and not approved. Manipulating the pulse generator without understanding can suppress rather than stimulate the axis.
This is something to take to a clinician. The Atlas can tell you what is known about kisspeptin & upstream control of the hpg axis in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Kisspeptin, encoded by KISS1 and acting via the KISS1R/GPR54 receptor, is the principal upstream activator of GnRH neurons. Hypothalamic KNDy neurons (kisspeptin, neurokinin B, dynorphin) in the arcuate nucleus are now considered the core of the GnRH pulse generator. Inactivating mutations in KISS1 or KISS1R cause hypogonadotropic hypogonadism and absent puberty; kisspeptin is under active investigation as a diagnostic and therapeutic tool.
The master switch sitting one level above GnRH, the true gatekeeper of the male axis.
What people take it for
These are the reasons people give for taking it. They are not effects it has been shown to have.
How it is supposed to work
Kisspeptin neurons sense steroid feedback and metabolic signals (including leptin) and drive pulsatile GnRH release. Within the arcuate nucleus, neurokinin B starts and dynorphin stops each pulse, while kisspeptin relays the signal to GnRH neurons. This KNDy circuit sets the frequency that ultimately determines LH, FSH, and testosterone output.
Kisspeptins are a family of peptides cleaved from the KISS1 precursor (kisspeptin-54 and shorter fragments) that share a common C-terminal that binds KISS1R.
Why kisspeptin is not a shortcut to higher testosterone
Because kisspeptin acts above GnRH, sustained administration can desensitize the axis just as continuous GnRH does, rather than reliably raising testosterone. Its likely clinical value is diagnostic (probing axis integrity) and in fertility, not as a self-administered testosterone booster. Gray-market 'kisspeptin' peptides are unapproved and unproven for that purpose.
What it does to fertility
Pulsatile kisspeptin (like pulsatile GnRH) can in principle stimulate gonadotropins and is being studied to induce or assess fertility; continuous exposure may instead suppress it. It is not an established fertility treatment.
What people get wrong
Often saidA kisspeptin nasal spray will boost your testosterone
ActuallyUnproven. Kisspeptin is investigational, and continuous dosing can desensitize the axis; marketed peptides are unregulated.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Receptor
- KISS1R (GPR54)
- Key neurons
- KNDy neurons in the arcuate nucleus
- Loss-of-function
- Hypogonadotropic hypogonadism, failed puberty
- Status
- Investigational, not an approved low-T treatment
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Kisspeptin & Upstream Control of the HPG Axis. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
KISS1R/GPR54 loss-of-function and hypogonadotropic hypogonadism2003
Inactivating mutations shown to cause failure of puberty and gonadotropin deficiency, establishing kisspeptin as essential to the axis
KNDy model of the GnRH pulse generatorEstablished in the literature
Neurokinin B and dynorphin shape pulsatile kisspeptin release that drives GnRH